Sands, Mark S.

AAV vector integration sites in mouse hepatocellular carcinoma

Donsante, A., Miller, D. G., Li, Y., Vogler, C., Brunt, E. M., Russell, D. W., & Sands, M. S. (2007) · Science

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 662

Gene therapy for lysosomal storage diseases

Sands, M. S., & Davidson, B. L. (2006) · Molecular Therapy

Lysosomal Storage Disorders ResearchVirus-based gene therapy research

Cited by 285

Marrow Stromal Cells and Osteoclast Precursors Differentially Contribute to TNF-α-Induced Osteoclastogenesis In Vivo

Kitaura, H., Sands, M. S., Aya, K., Zhou, P., Hirayama, T., Uthgenannt, B., Wei, S., Takeshita, S., Novack, D. V., Silva, M. J., et al. (2004) · The Journal of Immunology

Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies

Cited by 190

AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis

Griffey, M., Macauley, S. L., Ogilvie, J. M., & Sands, M. S. (2005) · Molecular Therapy

Lysosomal Storage Disorders ResearchRetinal Development and Disorders

Cited by 115

Gene targeting in vivo by adeno‐associated virus vectors

Miller, D. G., Wang, P.-R., Petek, L. M., Hirata, R. K., Sands, M. S., & Russell, D. W. (2006) · Nature Biotechnology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 105

The Role of Attenuated Astrocyte Activation in Infantile Neuronal Ceroid Lipofuscinosis

Macauley, S. L., Pekny, M., & Sands, M. S. (2011) · The Journal of Neuroscience

Lysosomal Storage Disorders ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 102